Events

Watch a rebroadcast of this virtual panel discussion, led by nephrology experts, where you can hear about the racial disparities that exist in autosomal dominant polycystic kidney disease.

Join us for part 2 of this informative international webinar where Professor Andrew Mallett, nephrologist and clinical researcher (Australia), and Dr Hila Rasouly, research scientist and genetic counselor (USA), discuss clinical genomics and its applications in kidney disease, including genetic testing for diagnosis and prognosis and the question of determining which patients to test, barriers to access, global differences across healthcare landscapes, and implications for the patient.

Join us for part 2 of this informative international webinar where Professor Andrew Mallett, nephrologist and clinical researcher (Australia), and Dr Hila Rasouly, research scientist and genetic counselor (USA), discuss clinical genomics and its applications in kidney disease, including genetic testing for diagnosis and prognosis and the question of determining which patients to test, barriers to access, global differences across healthcare landscapes, and implications for the patient.

Part 1 of this series described the fact that ADPKD is a metabolic reprogramming disease, which may benefit from novel diet strategies such as a ketogenic diet. Part 2 of this 3-part series will discuss and describe the use of a Plant-Focused Ketogenic Diet (PFKD) program for improved ADPKD outcomes.

Part 1 of this series described the fact that ADPKD is a metabolic reprogramming disease, which may benefit from novel diet strategies such as a ketogenic diet. Part 2 of this 3-part series will discuss and describe the use of a Plant-Focused Ketogenic Diet (PFKD) program for improved ADPKD outcomes.

Join us for Part II of our “Polycystic Kidney Disease Research – Past, Present, and Future” webinar where talented and emerging experts discuss efforts being made to further elucidate the molecular pathways contributing to disease and shed light on cutting edge research that may one day lead to improved options for patients living with PKD.

Join us for Part II of our “Polycystic Kidney Disease Research – Past, Present, and Future” webinar where talented and emerging experts discuss efforts being made to further elucidate the molecular pathways contributing to disease and shed light on cutting edge research that may one day lead to improved options for patients living with PKD.

In this event Dr Calvin Meaney and Dr Katie Cardone outline the role of both inpatient and outpatient clinical pharmacy services as well as discuss medication therapy challenges in managing patients with CKD.

In this event Dr Calvin Meaney and Dr Katie Cardone outline the role of both inpatient and outpatient clinical pharmacy services as well as discuss medication therapy challenges in managing patients with CKD.

Part 1 of this series described the fact that ADPKD is a metabolic reprogramming disease, which may benefit from novel diet strategies such as a ketogenic diet. Part 2 of this 3- part series discussed the use of a Plant-Focused Ketogenic Diet (PFKD) program for improved ADPKD outcomes. In Part 3 of this series, we will focus on meal planning, meal preparation and a food demonstration describing a “day in the life” when following a Plant-Focused Ketogenic Diet.

Part 1 of this series described the fact that ADPKD is a metabolic reprogramming disease, which may benefit from novel diet strategies such as a ketogenic diet. Part 2 of this 3- part series discussed the use of a Plant-Focused Ketogenic Diet (PFKD) program for improved ADPKD outcomes. In Part 3 of this series, we will focus on meal planning, meal preparation and a food demonstration describing a “day in the life” when following a Plant-Focused Ketogenic Diet.

Anemia is a well-known complication of chronic kidney disease (CKD) and the overall impact it has on patients who suffer from CKD is significant. In this informative webinar, renowned anemia expert, Dr Jay B Wish, will walk us through how managing patients with anemia in CKD has evolved over time and highlight recent scientific advancements that could potentially change the treatment landscape of anemia in CKD.